HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

disulfide poly(amido ethylenediamine)

used for plasmid delivery; structure in first source

Also Known As:

SS-PAED

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Bull, David A: 1 article (04/2007)
2.	Chang, Chien-Wen: 1 article (04/2007)
3.	Christensen, Lane V: 1 article (04/2007)
4.	Conners, Rafe: 1 article (04/2007)
5.	Feijen, Jan: 1 article (04/2007)
6.	Jackson, Heidi: 1 article (04/2007)
7.	Kim, Sung Wan: 1 article (04/2007)
8.	Yockman, James W: 1 article (04/2007)
9.	Zhong, Zhiyuan: 1 article (04/2007)

Related Diseases

1.	Ischemia 04/02/2007 - "In conclusion, SS-PAED mediated therapeutic delivery improves the efficacy of ischemia-inducible VEGF gene therapy both in vitro and in vivo and therefore, has potential for the promotion of neo-vascular formation and improvement of tissue function in ischemic myocardium."
2.	Myocardial Infarction 04/02/2007 - "Using SS-PAED, delivery of RTP-VEGF was investigated in a rabbit myocardial infarct model using 100 mug RTP-VEGF. "
3.	Infarction (Infarctions) 04/02/2007 - "Results showed up to 4 fold increase in VEGF protein expression in the region of the infarct compared to injections of SS-PAED/RTP-Luc. "
4.	Hypoxia (Hypoxemia) 04/02/2007 - "Delivery of the hypoxia-inducible vascular endothelial growth factor (RTP-VEGF) plasmid using a novel reducible disulfide poly(amido ethylenediamine) (SS-PAED) polymer carrier was studied in vitro and in vivo. "

Related Drugs and Biologics

1.	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
2.	disulfide poly(amido ethylenediamine)
3.	Proteins (Proteins, Gene)
4.	Polymers

Related Therapies and Procedures

1.	Injections